The Sp1 and CBF/NF-Y Transcription factors cooperatively regulate the mouse Pro-α3(V) collagen gene (Col5a3) in osteoblastic cells

Acta Medica Okayama

Volumn 64, Issue 2, 2010, Pages 95-108

  Wu, Yun Feng ^a   Matsuo, Noritaka ^a   Sumiyoshi, Hideaki ^a   Yoshioka, Hidekatsu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

CBF NF Y; Gene regulation; Osteoblastic cell; Spl; Type V collagen

Indexed keywords

RATTUS;

CCAAT BINDING FACTOR; COLLAGEN; PRO ALPHA3(V) COLLAGEN; PRO-ALPHA3(V) COLLAGEN; PROTEIN PRECURSOR; TRANSCRIPTION FACTOR SP1;

ANIMAL; ARTICLE; BINDING SITE; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PHYSIOLOGY; PROMOTER REGION; RAT; TRANSCRIPTION INITIATION SITE;

ANIMALS; BASE SEQUENCE; BINDING SITES; CCAAT-BINDING FACTOR; CELLS, CULTURED; COLLAGEN; GENE EXPRESSION REGULATION; MICE; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; PROMOTER REGIONS, GENETIC; PROTEIN PRECURSORS; RATS; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION INITIATION SITE;

EID: 77952311485     PISSN: 0386300X     EISSN: 0386300X     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Vuorio E and de Crombrugghe B, The family of collagen genes. Annu Rev Biochem (1990) 59: 837-872.
2. van der Rest M and Garrone R, Collagen family of proteins. FASEB J (1991) 5: 2814-2823.
3. Adachi E and Hayashi T, In vitro formation of hybrid fibrils of type V collagen and type I collagen. Limited growth of type I collagen into thick fibrils by type V collagen. Connect Tissue Res (1986) 14: 257-266.
4. Mendler M, Eich-Bender SG, Vaughn L, Winterhalter KH and Bruckner P, Cartilage contains mixed fibrils of collagen type II, IX, and XI. J Cell Biol (1989) 108: 191-197.
5. 2-terminal domain, a putative regulator of corneal fibrogenesis. J Cell Biol (1993) 121: 1181-1189.
6. Andrikopoulos K, Liu X, Keene DR, Jaenisch R and Ramirez F, Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet (1995) 9: 31-36.
7. Birk DE, Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron (2001) 32: 223-237.
8. Toriello HV, Glover TW, Takahara, K, Byers PH, Miller DE, Higgins and JV, Greenspan DS, A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito. Nat Genet (1996) 13: 361-365.
9. Michalickova K, Susic M, Willing MC, Wenstrup RJ and Cole WG, Mutation of the α2(V) chain of type V collagen impair matrix assembly and produce Ehlers-Dalos syndrome type I. Hum Mol Genet (1998) 7: 249-255.
10. Malfait F and De Paepe A, Molecular genetics in classic Ehlers-Danlos syndrome. Am J Med Genet Semin Med Genet (2005) 139C: 17-23.
11. Wenstrup RJ, Florer JB, Brunskill EW, Bell SM, Chervoneva I and Birk DE, Type V collagen controls the initiation of collagen fibril assembly. J Biol Chem (2004) 279: 53331-53337.
12. Rhodes RK and Miller EJ, Evidence for the existence of an α1(V) ff2(V) α3(V) collagen molecule in human placental tissue. Collagen Relat Res (1981) 1: 337-343.
13. Abedin MZ, Ayad S and Weiss JB, Isolation and native characterization of cysteine-rich collagens from bovine placental tissues and uterus and their relationship to types IV and V collagens. Biosci Rep (1982) 2: 493-502.
14. Fessler, JH and Fessler LI, in Structure and function of collagen types, Mayne R and Burgeson RE eds, Academic Press, Orland (1987) pp. 81-103.
15. Imamura Y, Scott IC and Greenspan DS, The pro-α3(V) collagen chain. J Biol Chem (2000) 275: 8749-8759.
16. Chernousov MA, Rothblum K, Tyler WA, Stahl RC and Carey DJ, Schwann cells synthesize type V collagen that contains a novel α4 chain. J Biol Chem (2000) 275: 28208-28215.
17. Yamaguchi K, Matsuo N, Sumiyoshi H, Fujimoto N, Iyama KI, Yanagisawa S and Yoshioka H, Pro-α3(V) collagen chain is expressed in bone and its basic N-terminal peptide adheres to osteosarcoma cells. Matrix Biol (2005) 24: 283-294.
18. Lee S and Greenspan DS, Transcriptional promoter of the human α1(V) collagen gene (COL5A1). Biochem J (1995) 310: 15-22.
19. Sakata-Takatani K, Matsuo N, Sumiyoshi H, Tsuda T and Yoshioka H, Identification of a functional CBF-binding CCAAT-like motif in the core promoter of the mouse pro-α1(V) collagen gene (Col5a1). Matrix Biol (2004) 23: 87-99.
20. Truter S, Di Liberto M, Inagaki Y and Ramirez F, Identification of an upstream regulatory region essential for cell type-specific transcription of the pro-α2(V) collagen gene (COL5A2). J Biol Chem (1992) 267: 25389-25395.
21. Penkov D, Tanaka S, Di Rocco G, Berthelsen J, Blasi F and Ramirez F, Cooperative interactions between PBX, PREP, and HOX proteins modulate the activity of the α2(V) collagen (COL5A2) promoter. J Biol Chem (2000) 275: 16681-16689.
22. Nagato H, Matsuo N, Sumiyoshi H, Sakata-Takatani K, Nasu M and Yoshioka H, The transcription factor CCAAT-binding factor CBF/NF-Y and two repressors regulate the core promoter of the human pro-α3(V) collagen gene (COL5A3). J Biol Chem (2004) 279: 46373-46383.
23. Elder GA, Liang Z, Li C and Lazzarini RA, Targeting of Sp1 to a non-Sp1 site in the human neurofilament (H) promoter via an intermediary DNA-binding protein. Nucleic Acids Res (1992) 20: 6281-6285.
24. Hagen G, Muller S, Beato M and Suske G, Sp1-mediated tran scriptional activation is repressed by Sp3. EMBO J (1994) 13: 3843-3851.
25. Matsuo N, Yu-HuaW, Sumiyoshi H, Sakata-Takatani K, Nagato H, Sakai K, Sakurai M and Yoshioka H, The transcription factor CCAAT-binding factor CBF/NF-Y regulates the proximal promoter activity in the human α1(XI) collagen gene (COL11A1). J Biol Chem (2003) 278: 32763-32770.
26. Chen C and Okayama H, High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol (1987) 7: 2745-2752.
27. Dignam, JD, Martin PL, Shastry BS and Roeder RG, Eukaryotic gene transcription with purified components. Methods Enzymol (1983) 101: 582-598.
28. Yaykasli KO, Oohashi T, Hirohata S, Hatipoglu OF, Inagawa k, Demircan K and Ninomiya Y, ADAMTS9 activation by interleukin 1/3 via NFATc1 in OUMS-27 chondrosarcoma cells and in human chondrocytes. Mol Cell Biochem (2009) 323: 69-79.
29. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA and Miller DM, Mitamysin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate gene in vitro and in vivo. J Clin Invest (1991)88: 1613-1621.
30. Tzaphlidou M, The role of collagen in bone structure: An image processing approach. Micron (2005) 36: 593-601.
31. Ramirez F, Tanaka S and Bou-Gharios G, Transcriptional regulation of the human α2(l) collagen gene (COL1A2), an informative model system to study fibrotic diseases. Matrix Biol (2006) 25: 365-372.
32. Slack JL, Liska DJ and Bornstein P, Regulation of expression of the type I collagen gene. Am J Med Genetics (1993) 45: 140-151.
33. Ihn H, Ohnishi K, Tawaki T, LeRoy EC and Trojanowska M, Transcriptional regulation of the human α2(l) collagen gene. J Biol Chem (1996) 271: 26717-26723.
34. Galera P, Park RW, Ducy P, Mattei MG and Karsenty G, c-Krox binds to several sites in the promoter of both mouse type I collagen. J Biol Chem (1996) 271: 21331-21339.
35. Hasegawa T, Takeuchi A, Miyaishi O, Isobe KI and de Crombregghe B, Cloning and characterization of a transcription factor that binds to the proximal promoters of the two mouse type I collagen genes. J Biol Chem (1997) 272: 4915-4923.
36. Karsenty G and de Crombregghe B, Two different negative and one positive regulatory factors interact with a short promoter segment of the α1(l) collagen gene. J Biol Chem (1990) 265: 9934-9942.
37. Ruteshouser EC and de Crombrugghe B, Characterization of two distinct positive cis-acting elements in the mouse α1(lll) collagen promoter. J Biol Chem (1989) 264: 13740-13744.
38. Yoshino T, Sumiyoshi H, Shin T, Matsuo N, Inagaki Y, Ninomiya Y and Yoshioka H, Multiple proteins are involved in the protein-DNA complex in the proximal promoter of the human α1(lll) collagen gene (COL3A1). Biochem Biophys Acta (2005) 1729: 94-104.
39. Sumiyoshi H, Matsuo N, Shin T, Shirabe K and Yoshioka H, Multifactor complex containing B element binding factor, BBF, and repressors regulate the human α1(lll) collagen gene (COL3A1). Acta Med Okayama (2006) 60: 181-189.
40. Lefebvre V, Huang W, Harley VR, Goodfellow PN and de Crombrugghe B, SOX9 is a potent activator of the chondrocyte-specific enhancer of the proct-1 (II) collagen gene. Mol Cell Biol (1997) 17: 2336-2346.
41. Bridgewater LC, Lefebvre V and de Crombrugghe B, Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem (1998) 273: 14998-15006.
42. Lefebvre V, Li P and de Crombrugghe B, A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chodrogenesis and cooperatively activate the type II collagen gene. EMBO J (1998) 17: 5718-5733.
43. Maity SN, Golumbek PT, Karsenty G and de Crombregghe B, Selective activation of transcription by a novel CCAAT binding factor. Science (1988) 241: 582-585.
44. Hatamochi A, Golumbek PT, van Schaftingen E and de Crombregghe B, A CCAAT DNA binding factor consisting of two different components that are both required for DNA binding. J Biol Chem (1988) 263: 5940-5947.
45. Coustry F, Maity SN and de Crombregghe B, Studies on transcriptin activation by the multimeric CCAAT-binding factor CBF. J Biol Chem (1995) 270: 468-475.
46. Hagen G, Muller S, Beato M and Suske G, Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Res (1992) 20: 5519-5525.
47. Majello B, De Luca P and Lania L, Sp3 is a bifunctional transcription regulator with modular independent activation and repression domains. J Biol Chem (1997) 272: 4021-4026.
48. Ducy P, Zhang R, Geoffroy V, Ridall A and Karsenty G, Osf2/ Cbfa1: a transcriptional activator of osteoblast differentiation. Cell (1997)89: 747-754.
49. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, BronsonRT, Gao YH, Inada Sato M, Okamoto R, Kitamura Y, Yoshiki S and Kishimoto T, Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblast. Cell (1997) 89: 755-764.
50. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB and Owen MJ, Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell (1997) 89: 765-771.
51. Kern B, Shen J, Starbuck M and Karsenty G, Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem (2001) 276: 7101-7107.